Drugs (Pharmaceuticals)

Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Bill

Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.

Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Study of Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Democratic Divisions Flare Over Tax Increases and Drug Pricing

In both the House and the Senate, Democrats are working to resolve their internal differences on a huge social policy measure that will require near-total unity to pass.

Democratic Divisions Flare Over Tax Increases and Drug Pricing

In both the House and the Senate, Democrats are working to resolve their internal differences on a huge social policy measure that will require near-total unity to pass.

Phony Diagnoses Hide High Rates of Drugging at Nursing Homes

At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.

Ohio Judge Reverses Order Requiring Covid Patient to Be Given Ivermectin

An intubated patient was prescribed the deworming drug by his doctor. Federal health officials have said that it has not been shown to be effective against the coronavirus and that it can be toxic in humans.

Ohio Judge Reverses Order Requiring Covid Patient to Be Given Ivermectin

An intubated patient was prescribed the deworming drug by his doctor. Federal health officials have said that it has not been shown to be effective against the coronavirus and that it can be toxic in humans.

Ohio Judge Reverses Order Requiring Covid Patient to Be Given Ivermectin

An intubated patient was prescribed the deworming drug by his doctor. Federal health officials have said that it has not been shown to be effective against the coronavirus and that it can be toxic in humans.

Ivermectin Won’t Treat Covid-19, but Demand Is High Anyway

The drug has spared hundreds of millions of Africans from serious parasites, but clinical trials have repeatedly failed to show that it is effective against Covid. Still, U.S. demand is high.

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval

The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval

The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval

The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

‘Nos complica la vida’: muchas empresarias deben soportar las comparaciones con Elizabeth Holmes, la fundadora de Theranos

Numerosas emprendedoras dicen que suelen compararlas con Holmes, la fundadora de Theranos, que pronto enfrentará un juicio por fraude.

Biden Falls Short on Pledge for U.S. to Be the World’s Vaccine ‘Arsenal,’ Experts Say

Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.

Sacklers Threaten to Pull Out of Opioid Settlement Without Broad Legal Immunity

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are shielded from lawsuits related to Purdue Pharma.

Sacklers Threaten to Pull Out of Purdue Pharma Opioids Settlement

In a rare court appearance, David Sackler said he and his family would withdraw their pledge to pay $4.5 billion, unless they are granted broad legal immunity.

Covid Vaccines Produced in Africa Are Being Exported to Europe

Johnson & Johnson is sending shots from South Africa to other parts of the world. African countries are waiting for most of the doses they’ve ordered.

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.

As Virus Cases Surge, Biden Administration Encourages More Use of Antibody Treatments

A top White House adviser said monoclonal antibody treatments, sometimes underused, could still be crucial in helping people with Covid-19 avoid getting very sick.

Some Are Chasing Extra Vaccine Shots, While Scientists Debate

Boosters may not be necessary yet, many experts say, and the pursuit of additional shots raises ethical questions.

F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Month

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Month

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturer

Emergent BioSolutions, which ruined 75 million vaccine doses at its Baltimore plant, disclosed records requests from Congress and federal and state law enforcement agencies.

U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturer

Emergent BioSolutions, which ruined 75 million vaccine doses at its Baltimore plant, disclosed records requests from Congress and federal and state law enforcement agencies.

Some Are Chasing Extra Vaccine Shots, While Scientists Debate

Boosters may not be necessary yet, many experts say, and the pursuit of additional shots raises ethical questions.

Vaccine Makers Are Asked to Expand Safety Studies on Children

The F.D.A. wants Pfizer and Moderna to increase the number of 5- to 11-year-olds who participate in trials of their coronavirus vaccines to ensure there is enough data about rare side effects.

Johnson & Johnson podría ser menos eficaz contra la variante delta

Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.

Johnson & Johnson podría ser menos eficaz contra la variante delta

Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.

Drug Distribution Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuit

The payout to New York will take place over the next 17 years, and joins a $26 billion deal to settle the thousands of nationwide lawsuits.

States and Cities Near Tentative $26 Billion Deal in Opioids Cases

The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.

Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuit

Three drug distributors and Johnson & Johnson are also on the verge of a $26 billion deal to settle the thousands of nationwide lawsuits.

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved

Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.

States and Cities Near Tentative $26 Billion Deal in Opioids Cases

The agreement would end thousands of lawsuits against the three largest distributors and Johnson & Johnson and require them to pay billions for addiction treatment and prevention.

How an Unproven Alzheimer’s Drug Got Approved

Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.

U.S. Officials Push Back on Pfizer’s Request for Booster Shot Approval

After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.

F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine

Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.

Biden to Urge More Scrutiny of Big Business

An order reflects the administration’s growing embrace of warnings by some economists that declining competition is hobbling the economy’s vitality.

Biden to Urge More Scrutiny of Big Business

An order reflects the administration’s growing embrace of warnings by some economists that declining competition is hobbling the economy’s vitality.

15 States Reach a Deal With Purdue Pharma Over Opioids

The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.

Biden Makes New Push for Vaccinations, but Experts Say More Is Needed

Some public health experts worry that the administration is not being aggressive enough in waging what the president calls a “wartime effort” to vaccinate the country.

Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.

Biotech Company That Botched Vaccines Faces Investor Revolt

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

Major Trial Against Opioid Suppliers Begins in New York

New York’s sweeping lawsuit is the first opioid case in which a jury rather than a judge will decide the outcome.

High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.

Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.

A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.

An U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.

Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.